ReviewTherapeutics and clinical risk management2015
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives.
Philipp Moog et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.